Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)
苯达莫司汀、长春新碱和泼尼松(BOP)与环磷酰胺、长春新碱和泼尼松(COP)治疗晚期惰性非霍奇金淋巴瘤和套细胞淋巴瘤的疗效比较:一项随机 III 期试验的结果(OSHO# 19)
期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-005-0023-2
Herold, M; Schulze, A; Niederwieser, D; Franke, A; Fricke, H J; Richter, P; Freund, M; Ismer, B; Dachselt, K; Boewer, C; Schirmer, V; Weniger, J; Pasold, R; Winkelmann, C; Klinkenstein, C; Schulze, M; Arzberger, H; Bremer, K; Hahnfeld, S; Schwarzer, A; Müller, C; Müller, Chr